07/30/2025
6:08 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2025
8:57 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2025
9:03 AM | Can-Fite BioPharma (Filer)
| Form 424B4 | |
07/28/2025
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
07/28/2025
6:02 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2025
1:34 PM | Can-Fite BioPharma (Filer)
| Form F-1/A | |
06/23/2025
3:15 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2025
8:02 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025
7:10 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2025
3:30 PM | Can-Fite BioPharma (Subject)
Orca Capital AG (Filed by)
| Form SCHEDULE 13G/A | |
04/17/2025
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for CANF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
04/17/2025
8:16 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2025
3:30 PM | Can-Fite BioPharma (Subject)
Orca Capital AG (Filed by)
| Form SCHEDULE 13G | |
04/15/2025
11:35 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2025
11:37 AM | Can-Fite BioPharma (Filer)
| Form 424B5 | |
04/14/2025
3:15 PM | Can-Fite BioPharma (Filer)
| Form POS AM | |
04/14/2025
7:35 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/14/2025
7:00 AM | Can-Fite BioPharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/14/2025
7:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/24/2025
8:01 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025
8:45 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2025
8:02 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/18/2025
7:32 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/03/2025
5:04 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025
6:04 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2025
4:33 PM | ARMISTICE CAPITAL, LLC (Filed by)
Can-Fite BioPharma (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
6:02 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
6:01 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
6:09 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2024
8:23 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024
6:03 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024
6:05 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/08/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
09/06/2024
3:30 PM | Can-Fite BioPharma (Filer)
| Form 424B3 | |
09/05/2024
11:15 PM | Can-Fite BioPharma (Filer)
| Form EFFECT | |
08/30/2024
3:18 PM | Can-Fite BioPharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
08/30/2024
3:18 PM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024
7:46 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Is Elon's empire crumbling? (Ad) The Tesla Shock Nobody Sees Coming
While headlines scream "Tesla is doomed"...
Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs.
One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. Click here to see the Tesla shock that could blindside everyone. |
08/12/2024
5:45 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2024
5:07 AM | Can-Fite BioPharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
